MRNA Exercise Disclosure
Mock James M · SEC Form 4 · Filed Oct 7, 2026
Exercise
Reported value range
Not reported
Mock James M Chief Financial Officer
MRNA
Moderna
MRNA
Transaction date
Oct 5, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 2 days later
MRNA daily price context
Close on/before transaction
$203.21
Oct 5, 2026
First close after public filing
$197
Oct 8, 2026
Return after filing · so far
+14.21%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,454 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001682852-26-000185
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$133.77K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA Current | Exercise | Oct 5, 2026 | Not reported |
| Moderna, Inc. MRNA | Disposition | Oct 5, 2026 | $133.77K |
| Moderna, Inc. MRNA | Exercise | Oct 5, 2026 | $0 |